Compare AANJANEYA LIFECARE with WYETH - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs WYETH - Comparison Results

WYETH 
   Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS WYETH DR. DATSONS LABS/
WYETH
 
P/E (TTM) x -10.9 27.7 - View Chart
P/BV x 0.2 5.3 3.0% View Chart
Dividend Yield % 0.0 1.3 -  

Financials

 DR. DATSONS LABS   WYETH
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
WYETH
Mar-13
DR. DATSONS LABS/
WYETH
5-Yr Chart
Click to enlarge
High Rs1261,044 12.0%   
Low Rs31818 3.8%   
Sales per share (Unadj.) Rs133.0298.6 44.5%  
Earnings per share (Unadj.) Rs0.257.2 0.3%  
Cash flow per share (Unadj.) Rs6.658.4 11.3%  
Dividends per share (Unadj.) Rs017.00 0.0%  
Dividend yield (eoy) %01.8 0.0%  
Book value per share (Unadj.) Rs128.8249.5 51.6%  
Shares outstanding (eoy) m31.6622.72 139.3%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.63.1 18.9%   
Avg P/E ratio x516.116.3 3,172.6%  
P/CF ratio (eoy) x11.815.9 74.3%  
Price / Book Value ratio x0.63.7 16.3%  
Dividend payout %029.7 0.0%   
Avg Mkt Cap Rs m2,47721,157 11.7%   
No. of employees `000NA0.5 0.0%   
Total wages/salary Rs m56400 14.0%   
Avg. sales/employee Rs ThNM13,787.4-  
Avg. wages/employee Rs ThNM813.0-  
Avg. net profit/employee Rs ThNM2,643.3-  
INCOME DATA
Net Sales Rs m4,2116,783 62.1%  
Other income Rs m79353 22.3%   
Total revenues Rs m4,2897,136 60.1%   
Gross profit Rs m5691,617 35.2%  
Depreciation Rs m20427 768.4%   
Interest Rs m4306 7,821.8%   
Profit before tax Rs m131,938 0.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m0-5 0.0%   
Tax Rs m6632 1.0%   
Profit after tax Rs m51,301 0.4%  
Gross profit margin %13.523.8 56.6%  
Effective tax rate %48.032.6 147.2%   
Net profit margin %0.119.2 0.6%  
BALANCE SHEET DATA
Current assets Rs m6,8526,984 98.1%   
Current liabilities Rs m6,7112,056 326.4%   
Net working cap to sales %3.372.6 4.6%  
Current ratio x1.03.4 30.1%  
Inventory Days Days16199 162.0%  
Debtors Days Days31824 1,330.4%  
Net fixed assets Rs m3,673244 1,503.5%   
Share capital Rs m317227 139.3%   
"Free" reserves Rs m3,7615,441 69.1%   
Net worth Rs m4,0785,668 71.9%   
Long term debt Rs m1,67125 6,683.2%   
Total assets Rs m12,6337,901 159.9%  
Interest coverage x1.0353.3 0.3%   
Debt to equity ratio x0.40 9,290.1%  
Sales to assets ratio x0.30.9 38.8%   
Return on assets %3.416.5 20.8%  
Return on equity %0.122.9 0.5%  
Return on capital %7.734.0 22.5%  
Exports to sales %22.90.2 10,493.7%   
Imports to sales %14.336.3 39.3%   
Exports (fob) Rs m96415 6,513.5%   
Imports (cif) Rs m6022,465 24.4%   
Fx inflow Rs m96415 6,342.1%   
Fx outflow Rs m6072,677 22.7%   
Net fx Rs m357-2,662 -13.4%   
CASH FLOW
From Operations Rs m1,345923 145.7%  
From Investments Rs m-2,256317 -711.8%  
From Financial Activity Rs m-1,200-481 249.4%  
Net Cashflow Rs m-2,111759 -278.1%  

Share Holding

Indian Promoters % 4.5 0.0 -  
Foreign collaborators % 0.0 51.1 -  
Indian inst/Mut Fund % 0.0 11.3 -  
FIIs % 1.4 7.2 18.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 30.4 309.5%  
Shareholders   20,807 21,978 94.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   ALEMBIC PHARMA  DISHMAN PHARMA  TTK HEALTHCARE  ASTRAZENECA PHARMA  DIVIS LABORATORIES  

Compare DR. DATSONS LABS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Rallies 584 Points; Kotak Mahindra Bank & HDFC Bank Among Top Nifty Gainers(Closing)

Indian share markets witnessed buying interest during closing hours and ended today's volatile session higher.

Related Views on News

MSTC IPO: Should You Bet on This State-Run E-Commerce Player? (IPO)

Mar 13, 2019

Should you subscribe to the IPO of MSPC Limited?

MSTC IPO: Should You Bet on This State-Run E-Commerce Player? (IPO)

Mar 13, 2019

Should you subscribe to the IPO of MSPC Limited?

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market(Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

Charge Your Portfolio with this Smallcap Proxy Play on India's EV Revolution(Profit Hunter)

Mar 5, 2021

This could be the biggest wealth creator of the decade.

Gold 65,000 and Silver 84,000 in 2022

Feb 26, 2021

In this episode of the Investor Hour, India's #1 trader, Vijay Bhambwani, talks to us about the stock market, his new targets for gold and silver, the best long-term investment opportunity, and a lot more.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 8-QTR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS